Wolff, J.; Moritz, T.; Schlottau, K.; Hoffmann, D.; Beer, M.; Hoffmann, B.
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus. Vaccines 2021, 9, 4.
https://doi.org/10.3390/vaccines9010004
AMA Style
Wolff J, Moritz T, Schlottau K, Hoffmann D, Beer M, Hoffmann B.
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus. Vaccines. 2021; 9(1):4.
https://doi.org/10.3390/vaccines9010004
Chicago/Turabian Style
Wolff, Janika, Tom Moritz, Kore Schlottau, Donata Hoffmann, Martin Beer, and Bernd Hoffmann.
2021. "Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus" Vaccines 9, no. 1: 4.
https://doi.org/10.3390/vaccines9010004
APA Style
Wolff, J., Moritz, T., Schlottau, K., Hoffmann, D., Beer, M., & Hoffmann, B.
(2021). Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus. Vaccines, 9(1), 4.
https://doi.org/10.3390/vaccines9010004